Clinical Trial Update: Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sirolimus with low-dose warfarin for refractory paroxysmal nocturnal hemoglobinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• Sirolimus (Sirolimus)
• Warfarin (warfarin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 4 | Status: UNKNOWN